Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes

Raquel Cortés1, Esther Roselló-Lletí, Miguel Rivera

  • 1Cardiocirculatory Unit, Research Center, Hospital Universitario La Fe, Valencia, Spain.

Cardiovascular Research
|October 13, 2009
PubMed

Insights

Heart failure alters cell nucleus transport, increasing key protein levels like importins and exportins. Nuclear pore complexes in ischemic hearts show altered structure, impacting cellular function.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Molecular Medicine

Background:

  • The cell nucleus's role in heart failure (HF) pathogenesis is largely unexplored.
  • Understanding nucleocytoplasmic transport is crucial for elucidating HF mechanisms.

Purpose of the Study:

  • To investigate the impact of heart failure on nucleocytoplasmic transport.
  • To analyze changes in nuclear pore complex (NPC) density and morphology in HF.

Main Methods:

  • Western blotting of human heart samples (ischaemic, dilated, and control).
  • Fluorescence microscopy for protein distribution and electron microscopy for NPC structure.
  • Quantitative analysis of nucleocytoplasmic machinery proteins and NPC characteristics.

Main Results:

  • Elevated levels of importins (IMP-beta3, IMP-alpha2) and exportins (EXP-1, EXP-4) in both ischaemic (ICM) and dilated (DCM) heart failure.
  • Increased RanGTPase-activating proteins (RanGAP1, RanGAP1u) in ICM and DCM.
  • Higher nucleoporin p62 levels in ICM and DCM, with NPCs showing altered diameter and configuration in ICM.

Conclusions:

  • Heart failure significantly affects nucleocytoplasmic trafficking machinery.
  • Specific proteins involved in nuclear transport are upregulated in human HF hearts.
  • NPCs exhibit structural modifications in ischaemic heart failure, suggesting a role in disease progression.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...